PIM
BCAB icon

Platinum Investment Management’s BioAtla BCAB Stock Holding History

Platinum Investment Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,825
Closed -$456K – 132
2022
Q1 		$456K Hold
1,825
– – 0.01% 110
2021
Q4 		$1.79M Buy
1,825
+692
+61% +$885K 0.05% 96
2021
Q3 		$1.67M Buy
1,133
+459
+68% +$894K 0.05% 106
2021
Q2 		$1.43M Hold
674
– – 0.03% 108
2021
Q1 		$1.71M Sell
674
-726
-52% -$1.86M 0.04% 97
2020
Q4 		$2.38M Buy
+1,400
New +$2.34M 0.05% 86

Other funds holding BCAB

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Platinum Investment Management's BCAB Position: Q2 2022 in Review

Platinum Investment Management sold out of BioAtla (BCAB) in Q2 2022, closing a stake of 1,825 shares — an estimated $456K sold.

Platinum Investment Management first reported a position in BCAB in Q4 2020 and held it in 6 quarters. The position peaked at $2.38M in Q4 2020. 76 funds tracked by Wall St. Rank hold BCAB as of Q2 2022.

  • Platinum Investment Management reported no remaining BioAtla position as of Q2 2022 after selling out during the quarter.
  • Platinum Investment Management sold 1,825 BioAtla shares in Q2 2022, an estimated $456K.
  • Platinum Investment Management first reported a position in BioAtla in Q4 2020 and held it in 6 quarters.
  • Platinum Investment Management's BioAtla position peaked at $2.38M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held BioAtla as of Q2 2022.

Based on Platinum Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.